This HTML5 document contains 198 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://dx.doi.org/10.1097/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q38630825
rdf:type
wikibase:Item
schema:description
επιστημονικό άρθρο article scientifique teaduslik artikkel 2017年论文 научная статья artículo científico scientific article published on 08 August 2017 vetenskaplig artikel artículu científicu espublizáu en 2017 სამეცნიერო სტატია artigo científico 2017年论文 wetenschappelijk artikel article científic bilimsel makale מאמר מדעי 2017年论文 научни чланак 2017 nî lūn-bûn artikel ilmiah artikull shkencor scienca artikolo tudományos cikk บทความทางวิทยาศาสตร์ 2017년 논문 wissenschaftlicher Artikel наукова стаття, опублікована в серпні 2017 vedecký článok vědecký článek বৈজ্ঞানিক নিবন্ধ 2017年論文 artigo científico مقالة علمية نشرت في 08 أغسطس 2017 vitenskapelig artikkel videnskabelig artikel scientific article published on 08 August 2017 2017年論文 artigo científico мақолаи илмӣ scientific article published on 08 August 2017 articol științific vitskapeleg artikkel 2017年论文 научни чланак научна статия articolo scientifico artykuł naukowy 2017年の論文 2017年論文 artikulong pang-agham 2017年论文 tieteellinen artikkeli article scientific 2017年論文 bài báo khoa học naučni članak 2017年论文 2017年論文
p:P577
wds:Q38630825-BAC23406-086B-4E5A-8770-79C3386668C0
wdt:P577
2017-08-08T00:00:00Z
p:P407
wds:Q38630825-5DEDF7F5-F63F-428F-854D-821A7AB3773A
wdt:P407
wd:Q1860
p:P2860
wds:Q38630825-046DB298-A216-40A8-90CB-A9AFA1556E74 wds:Q38630825-0D0A86DA-1208-434A-98E7-20B9E78ADBE8 wds:Q38630825-0F71416B-A82D-484A-A642-466B30BFF765 wds:Q38630825-182725BE-B2D2-4028-B90F-F3372E7326DE wds:Q38630825-192659B7-21C1-4B23-8E5E-035E97D20CBB wds:Q38630825-1F929B7F-7C66-4FFF-8DEC-D375D91A5956 wds:Q38630825-27C6963B-EA10-4FC1-A63E-2138483E2A4D wds:Q38630825-33E49D5D-775B-4A1D-B377-3C38170D073E wds:Q38630825-3DB7A973-DD09-4F7D-AB8A-3D58F8F93BE0 wds:Q38630825-B9820391-4C75-48B0-8CD2-C027DD10F1F7 wds:Q38630825-C811D321-BAC6-469F-9EE9-8EEE4F047010 wds:Q38630825-C8FD8F23-C186-4613-BE15-DD73A5F51E79 wds:Q38630825-CA287357-49EB-4428-8BA1-4C0A892BB944 wds:Q38630825-D750554C-97BA-4521-956C-DF237C31EAE3 wds:Q38630825-DC02A07B-B084-4E8A-BA27-7C72C43D67B9 wds:Q38630825-DFB1CCCE-3070-4BAB-8217-C4D7A4910911 wds:Q38630825-E6824A66-CEB0-452B-AA1D-12EE55C45BBD wds:Q38630825-EBACDFD7-A6DE-4384-82B8-1E49FFF3F8FD wds:Q38630825-F8302412-10B3-4B7F-8A10-2281864C76A9 wds:Q38630825-FADF104A-47E7-473C-A63B-4A8389E7672A wds:Q38630825-4E4C93DE-D96E-4C12-A9CE-8C74C7487BA7 wds:Q38630825-4EE43D57-A4F9-4A57-A81F-D705F58B6386 wds:Q38630825-50F58416-558B-4894-A3A3-920F4822F6E5 wds:Q38630825-513016D5-BB7B-4F25-BFE2-E81369119B66 wds:Q38630825-5734C0B7-9503-4F02-AB20-8872D7520A42 wds:Q38630825-60825F47-7CF2-4F31-A4D4-EA652E098484 wds:Q38630825-60DF5811-23D6-4A97-A12F-B890BAB28290 wds:Q38630825-74E1B790-10AB-4E86-863D-DDB21AFFF13E wds:Q38630825-839B47F9-FFB8-4E22-9008-654F901EC35B wds:Q38630825-83C605EF-123B-4372-B58E-5CBB95EFD69C wds:Q38630825-859FDC3B-E10C-4C75-B73D-7B75AC4B72A7 wds:Q38630825-86275FEA-966C-4B8E-9BE6-77767068C03C wds:Q38630825-89640A57-CA43-45A8-A247-BA2CFF1DC34C wds:Q38630825-91051E40-7F02-426E-A84F-63F0EF88B85C wds:Q38630825-98CD9865-B9F8-4BDB-8FC1-2F38EDF960DA wds:Q38630825-9F0AC1E2-4577-4478-B82C-3F3F0768D3CF wds:Q38630825-A082A6EF-BBC5-4008-907E-2F58105BF487 wds:Q38630825-ABCC4D1D-419D-4884-B811-150BD5226968 wds:Q38630825-AC1938FC-42F6-438E-A6B3-1C4FF36C8D7E wds:Q38630825-B337829F-02C5-4000-8D69-3279F567CC4A wds:Q38630825-B5AE149B-D0BE-4D2E-BE03-F8053E48D3A9 wds:Q38630825-B947029C-87A0-42B3-BBAA-68950F5E96C4
wdt:P2860
wd:Q46788761 wd:Q36715888 wd:Q35851946 wd:Q46886196 wd:Q41240756 wd:Q79744901 wd:Q38852539 wd:Q44538133 wd:Q44710801 wd:Q43049753 wd:Q42536705 wd:Q33747095 wd:Q61643951 wd:Q30707332 wd:Q24235667 wd:Q36703845 wd:Q34660736 wd:Q44669320 wd:Q44156743 wd:Q45834186 wd:Q52880030 wd:Q35823305 wd:Q54393209 wd:Q38185057 wd:Q35765265 wd:Q35635609 wd:Q73964547 wd:Q46013607 wd:Q40521811 wd:Q44291445 wd:Q73017881 wd:Q45218475 wd:Q48698963 wd:Q31995598 wd:Q46407545 wd:Q74336674 wd:Q33939024 wd:Q84135235 wd:Q69903875 wd:Q41746381 wd:Q34522671 wd:Q37942066
p:P2093
wds:Q38630825-97F0F298-BC91-4A98-B80F-EBE3D8E1CD71 wds:Q38630825-964E51AD-986A-44BD-9530-E87407E90C3A wds:Q38630825-938164E9-F6E7-4E59-94BE-0078FE25639F wds:Q38630825-7FBC94BC-A530-4326-A033-CDB3343DE916 wds:Q38630825-81EB7B35-839A-4755-B3C8-CAAB29348D3E wds:Q38630825-FA1CF8DC-A01B-4752-91E9-BA3E50E9616B wds:Q38630825-CEB70369-D498-4523-8B93-B5284FE29839 wds:Q38630825-E5776D09-7861-4434-8FCC-15402623CE50
wdt:P2093
Miguel Gutiérrez J Javier Meana Oiane Mentxaka Rafael Segarra Arantzazu Zabala Imanol Querejeta Amaia Ugarte Marta Alonso
rdfs:label
A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients
skos:prefLabel
A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients
schema:name
A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients
p:P50
wds:Q38630825-E40C81D8-4FFF-4073-A031-3C68CDB6AC5B wds:Q38630825-CCE735F9-BE14-4204-87D9-914E1EB22583
wdt:P50
wd:Q61658933 wd:Q56995383
p:P1476
wds:Q38630825-4E07DDAC-4A6C-426A-A5D3-6C77EF9DBC27
wdt:P1476
A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients
p:P304
wds:Q38630825-728F900B-8EFA-49AB-993E-0F1FC0B8F2A3
wdt:P304
569-577
p:P31
wds:Q38630825-02AFB0EA-712B-46B0-808E-1F8D2C9546D2
wdt:P31
wd:Q13442814
p:P921
wds:Q38630825-ED7CC99A-9223-4752-8BDF-D8668E3ABF9A
wdt:P921
wd:Q170082
p:P698
wds:Q38630825-9765AE91-6F1B-48E5-AE05-E871B8F39B9D
wdtn:P698
n11:28796022
wdt:P698
28796022
p:P1433
wds:Q38630825-4AD299F9-D5D8-48A9-AE4D-6DB9FD331510
wdt:P1433
wd:Q6294969
p:P433
wds:Q38630825-840FB9D4-F161-4E59-8929-A8BA26AB71B2
p:P478
wds:Q38630825-35056088-9A86-4129-BF22-F2C644D75936
wdt:P433
5
wdt:P478
37
p:P356
wds:Q38630825-ACB2FC44-7CC3-43FB-BED3-7F0F204C5F96
wdtn:P356
n12:JCP.0000000000000770
wdt:P356
10.1097/JCP.0000000000000770
p:P932
wds:Q38630825-EF583655-5FFD-4EF4-83A1-2C6681BB0708
wdt:P932
5596831